SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001064901-15-000003
Filing Date
2015-06-05
Accepted
2015-06-05 16:46:05
Documents
1
Period of Report
2015-06-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3878
  Complete submission text file 0001064901-15-000003.txt   5431
Mailing Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 225 LONG AVENUE HILLSIDE NJ 07205
Business Address
KAY CHRISTINA (Reporting) CIK: 0001064901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31668 | Film No.: 15916454